Item

Newly Diagnosed Patients (95% CI)

Previously Diagnosed Patients (95% CI)

Total (95% CI)

DST

193 (100%)

-

17 (100%)

-

210 (100%)

Sensitive to all

150 (77.7%)

78.3 - 81.3

5 (29.4%)

155 (73.8%)

70.1 - 79.1

Mono Resistance TB

Isoniazid (H)

30 (16.0%)

21.1 - 24.6

7 (41.2%)

1.1 - 10.6

37 (17.6%)

24.5 - 28.0

Rifampicin (R)

4 (2.1%)

3.31 - 7.20

4 (23.5%)

1.54 - 1.99

8 (3.8%)

4.8 - 11.8

Ethambutol (E)

20 (10.0%)

23.2 - 26.7

9 (52.9%)

1.21 - 4.74

29 (13.8%)

25.4 - 28.9

Streptomycin (S)

18 (18.3%)

24.4 - 30.8

10 (58.8%)

1.15 - 1.67

28 (13.3%)

29.8 - 33.2

Multi-Drug Resistance TB (MDRTB)

H + R

4 (2.1%)

2.2 - 6.1

4 (23.5%)

1.54 - 1.99

8 (3.8%)

3.8 - 7.7

H + R + E

1 (0.5%)

0.3 - 0.7

1 (5.9%)

1.82 - 2.07

2 (1.0%)

1.0 - 3.0

H + R + S

-

-

-

-

-

-

H + R + E + S

-

-

-

-

-

-

Total MDR-TB

5 (2.6%)

1.7 - 3.4

5 (29.4%)

25.6 - 32.7

10 (4.8%)

3.8 - 6.1

Other resistance patterns

H + E

11 (5.7%)

3.8 - 7.7

3 (17.6%)

1.62 - 2.03

14 (6.7%)

4.8 - 8.7

H + S

7 (3.6%)

1.7 - 5.0

3 (17.6%)

1.62 - 2.03

10 (4.8)

2.9 - 6.8

H + E + S

2 (1.0%)

0.98-3.0

-

-

2 (1.0%)

2.0 - 3.0

R + E

2 (1.0%)

0.98 - 3.0

2 (11.8%)

1.71 - 2.05

4 (1.9%)

1.1 - 3.9

E + S

11 (5.7%)

3.7 - 7.7

1 (5.9%)

1.82 - 2.03

12 (5.7%)

3.8 - 3.9

R + S

5 (2.6%)

0.65 - 4.6

-

-

5 (2.4%)

2.0 - 4.3

R + E + S

-

-

-

-

-

-